Even though PTEN mutations are not frequently observed in myeloid malignancies (1%), PTEN protein is often inactivated in acute myeloid leukemia (AML) and chronic myeloid leukemia [113]. Here, PTEN is linked to chronic myelogenous leukemia, BCR-ABL1 positive.